Paxlovid is now approved for treating adults. Results from a pivotal clinical showed that Paxlovid led to an 86% reduction in COVID-19-related hospitalization or death from any cause compared to a placebo.
The post FDA Nod Makes Pfizer’s Paxlovid The First Approved Oral COVID-19 Antiviral Drug appeared first on Above the Law.
from Above the Law https://ift.tt/ce0QlBu
via IFTTT